CBD

CBD is the second most common cannabinoid from the plant of cannabis. In contrast to THC, CBD is not psychoactive and the reduced side effects associated to its administration makes it as important as THC regarding its therapeutic properties.

THC

D9THC is the most common cannabinoid from the cannabis plant. Better known as THC, it has psychoactive properties and its effects include altered sensory perception and reduced short-term memory.

CBDV

CBDV is a non-psychoactive cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.

CBN

CBN is a cannabinoid with weak psycho-active properties and some therapeutic potential related to cancer, pain, ALS and eating disorders.

Pain

Pain is a very good target for therapeutic cannabinoids. Many endocannabinoids, plant cannabinoids and cannabinoid receptors have been linked to pain management or analgesia.

THCVA

THCVA binds to several receptor (of the TRP class) but its exact physiological function is still under investigation.

CBGV

CBGV interacts with several receptors and may have anti-inflammatory and analgesic properties but this is still under investigation.

THCA

THCA is a precursor in THC synthesis (decarboxylation). THCA is not psychoactive and has several therapeutic properties.

CBGA

CBGA is a precursor for the production of THC but has some therapeutic, anti-inflammatory, value as well. Given the number of receptor interactions CBGA is likely to have more therapeutic properties.

CBDA

CBDA is a precursor of CBD (obtained by decarboxylation of CBDA) that has physiological and therapeutic properties of its own right.